Type 2 Diabetes

Postmenopausal women with type 2 diabetes have increased bone mineral content and lower bone turnover markers vs. those with normal or impaired glucose tolerance, according to data published in the Journal of Bone and Mineral Research.

Adults with type 2 diabetes assigned a novel dual GIP/GLP-1 receptor agonist for 40 weeks experienced significant reductions in HbA1c and body weight compared with those assigned placebo, according to top-line data from the SURPASS-1 study.

Type 2 diabetes agents with proven cardiovascular benefit may be useful for patients with type 1 diabetes to prevent atherosclerotic CVD, but more robust data are needed for the type 1 population, according to two speakers who debated the issue.

Patients with type 2 diabetes had a high or very high risk for fatal MI or stroke, according to a study published in the European Journal of Preventive Cardiology.

Women from China who had early menarche were more likely to develop type 2 diabetes as adults, with the risk higher for those with nonideal cardiovascular health, according to data from the REACTION study.

The benefits of dapagliflozin remain consistent in patients with chronic kidney disease, with and without type 2 diabetes, independent of baseline CV status, according to an analysis of the DAPA-CKD trial.

Researchers from Canada observed no link between higher doses of sitagliptin and increased risk for congestive heart failure in a cohort of patients older than 66 years who had both type 2 diabetes and chronic kidney disease.

Among participants in the Look AHEAD trial of an intensive lifestyle intervention for weight loss, there was no difference in total Medicare spending between the intervention and control group over a 4-year period, according to study data.

Hyperglycemia is associated with a higher likelihood for mortality, and the odds are greater for adults without diabetes and for those meeting type 2 diabetes targets, according to study data.

Mexican adults with diabetes living in areas of high social deprivation and low health care resources are significantly more likely to be hospitalized for COVID-19 complications compared with adults living in higher-resource settings.